These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Should albuminuria be a therapeutic target in patients with hypertension and diabetes? de Zeeuw D Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105 [TBL] [Abstract][Full Text] [Related]
3. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
4. Combating diabetic nephropathy with drug therapy. Martins D; Norris K Curr Diab Rep; 2001 Oct; 1(2):148-56. PubMed ID: 12643111 [TBL] [Abstract][Full Text] [Related]
6. MicroAlbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong. Yeung VT; Lee KF; Chan SH; Ho LF; Leung SK; Wong HY; Hong Kong Med J; 2006 Jun; 12(3):185-90. PubMed ID: 16760545 [TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. McKenna K; Thompson C Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with essential hypertension and microalbuminuria. Redon J Drugs; 1997 Dec; 54(6):857-66. PubMed ID: 9421693 [TBL] [Abstract][Full Text] [Related]
9. Systematic review on urine albumin testing for early detection of diabetic complications. Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545 [TBL] [Abstract][Full Text] [Related]
10. Hypertension and renal disease: role of microalbuminuria. Janssen WM; de Jong PE; de Zeeuw D J Hypertens Suppl; 1996 Dec; 14(5):S173-7. PubMed ID: 9120675 [TBL] [Abstract][Full Text] [Related]
11. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus. Mogensen CE; Petersen MM; Hansen KW; Christensen CK J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502 [TBL] [Abstract][Full Text] [Related]
12. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes. Shigihara T; Sato A; Hayashi K; Saruta T Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130 [TBL] [Abstract][Full Text] [Related]
13. Drug treatment for hypertensive patients in special situations: diabetes and hypertension. Mogensen CE Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111 [TBL] [Abstract][Full Text] [Related]
14. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A; Bashir K; Anwar E Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953 [TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive therapy in diabetes mellitus]. Hess B Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus. Marshall SM Diabet Med; 1999 May; 16(5):358-72. PubMed ID: 10342335 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Thomas MC; Atkins RC Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404 [TBL] [Abstract][Full Text] [Related]
18. Hypertension and diabetes: the scope of the problem. Parving HH Blood Press Suppl; 2001; 2():25-31. PubMed ID: 11465914 [TBL] [Abstract][Full Text] [Related]
19. [Microalbuminuria: cardiovascular and renal risk factors underestimated in clinical practice]. Zanella MT Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):313-21. PubMed ID: 16767297 [TBL] [Abstract][Full Text] [Related]